ATE252590T1 - Phosphorylierte derivate des diaryl 1,3,4 oxadiazolon - Google Patents
Phosphorylierte derivate des diaryl 1,3,4 oxadiazolonInfo
- Publication number
- ATE252590T1 ATE252590T1 AT99904270T AT99904270T ATE252590T1 AT E252590 T1 ATE252590 T1 AT E252590T1 AT 99904270 T AT99904270 T AT 99904270T AT 99904270 T AT99904270 T AT 99904270T AT E252590 T1 ATE252590 T1 AT E252590T1
- Authority
- AT
- Austria
- Prior art keywords
- oxadiazolone
- diaryl
- phosphorylated derivatives
- derivatives
- solvate
- Prior art date
Links
- WTSXVIMLKCKWIW-UHFFFAOYSA-N 3h-1,3,4-oxadiazol-2-one Chemical compound O=C1NN=CO1 WTSXVIMLKCKWIW-UHFFFAOYSA-N 0.000 title 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical class C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 title 1
- 102000004257 Potassium Channel Human genes 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 abstract 1
- 108020001213 potassium channel Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
- C07F9/65306—Five-membered rings containing two nitrogen atoms
- C07F9/65312—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7292698P | 1998-01-29 | 1998-01-29 | |
| PCT/US1999/001587 WO1999038873A1 (en) | 1998-01-29 | 1999-01-26 | Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE252590T1 true ATE252590T1 (de) | 2003-11-15 |
Family
ID=22110595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99904270T ATE252590T1 (de) | 1998-01-29 | 1999-01-26 | Phosphorylierte derivate des diaryl 1,3,4 oxadiazolon |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5939405A (de) |
| EP (1) | EP1056754B1 (de) |
| JP (1) | JP2002501926A (de) |
| AT (1) | ATE252590T1 (de) |
| AU (1) | AU730592B2 (de) |
| CA (1) | CA2318817A1 (de) |
| DE (1) | DE69912250T2 (de) |
| DK (1) | DK1056754T3 (de) |
| ES (1) | ES2209394T3 (de) |
| PT (1) | PT1056754E (de) |
| WO (1) | WO1999038873A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204257B1 (en) * | 1998-08-07 | 2001-03-20 | Universtiy Of Kansas | Water soluble prodrugs of hindered alcohols |
| US6297241B1 (en) | 1999-01-29 | 2001-10-02 | Bristol-Myers Squibb Company | Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| IL144540A0 (en) * | 1999-01-29 | 2002-05-23 | Bristol Myers Squibb Co | Carbamate derivatives of diaryl 1,3,4,-oxadiazolone |
| US6362172B2 (en) | 2000-01-20 | 2002-03-26 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| US6448401B1 (en) | 2000-11-20 | 2002-09-10 | Bristol-Myers Squibb Company | Process for water soluble azole compounds |
| GB0119435D0 (en) * | 2001-02-15 | 2001-10-03 | Aventis Pharm Prod Inc | Method of treating of demyelinating diseases or conditions |
| US6930100B2 (en) * | 2002-03-20 | 2005-08-16 | Bristol-Myers Squibb Company | Phosphate prodrugs of fluoroxindoles |
| US20070075286A1 (en) * | 2005-10-04 | 2007-04-05 | Par Technologies, Llc | Piezoelectric valves drive |
| US9757399B2 (en) | 2006-10-31 | 2017-09-12 | Jal Therapeutics, Inc. | Butyrylcholinesterase inhibitors |
| FI20070574A0 (fi) * | 2007-07-30 | 2007-07-30 | Kuopion Yliopisto | Vesiliukoinen propofolin etylideenifosfaatti-aihiolääke |
| EP2291084A4 (de) | 2008-05-20 | 2012-04-25 | Neurogesx Inc | Carbonat-prodrugs und verfahren zu ihrer verwendung |
| JP5757864B2 (ja) | 2008-05-20 | 2015-08-05 | ニューロジェシックス， インコーポレイテッド | 水溶性アセトアミノフェン類似体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH583213A5 (de) * | 1973-05-21 | 1976-12-31 | Ciba Geigy Ag | |
| DK570987A (da) * | 1986-12-01 | 1988-06-02 | Hoffmann La Roche | Oxadiazol-, thiadiazol- og triazolforbindelser |
| IT1251488B (it) * | 1991-09-17 | 1995-05-15 | Mini Ricerca Scient Tecnolog | Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida |
| US5234947A (en) * | 1991-11-07 | 1993-08-10 | New York University | Potassium channel activating compounds and methods of use thereof |
| US5547966A (en) * | 1993-10-07 | 1996-08-20 | Bristol-Myers Squibb Company | Aryl urea and related compounds |
| TW467902B (en) * | 1996-07-31 | 2001-12-11 | Bristol Myers Squibb Co | Diphenyl heterocycles as potassium channel modulators |
-
1999
- 1999-01-26 AU AU24703/99A patent/AU730592B2/en not_active Ceased
- 1999-01-26 JP JP2000529340A patent/JP2002501926A/ja active Pending
- 1999-01-26 AT AT99904270T patent/ATE252590T1/de not_active IP Right Cessation
- 1999-01-26 DK DK99904270T patent/DK1056754T3/da active
- 1999-01-26 DE DE69912250T patent/DE69912250T2/de not_active Expired - Fee Related
- 1999-01-26 ES ES99904270T patent/ES2209394T3/es not_active Expired - Lifetime
- 1999-01-26 CA CA002318817A patent/CA2318817A1/en not_active Abandoned
- 1999-01-26 WO PCT/US1999/001587 patent/WO1999038873A1/en active IP Right Grant
- 1999-01-26 US US09/237,752 patent/US5939405A/en not_active Expired - Fee Related
- 1999-01-26 EP EP99904270A patent/EP1056754B1/de not_active Expired - Lifetime
- 1999-01-26 PT PT99904270T patent/PT1056754E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002501926A (ja) | 2002-01-22 |
| CA2318817A1 (en) | 1999-08-05 |
| DE69912250T2 (de) | 2004-07-29 |
| PT1056754E (pt) | 2004-03-31 |
| EP1056754A4 (de) | 2002-03-06 |
| US5939405A (en) | 1999-08-17 |
| AU2470399A (en) | 1999-08-16 |
| WO1999038873A1 (en) | 1999-08-05 |
| AU730592B2 (en) | 2001-03-08 |
| DK1056754T3 (da) | 2004-02-16 |
| EP1056754B1 (de) | 2003-10-22 |
| ES2209394T3 (es) | 2004-06-16 |
| DE69912250D1 (de) | 2003-11-27 |
| EP1056754A1 (de) | 2000-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY115935A (en) | 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators | |
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| MY117896A (en) | Quinazoline derivatives | |
| MY132671A (en) | Substituted 6,6-hetero-bicyclic derivatives | |
| RS81904A (en) | Phosphate prodrugs of fluorooxindoles | |
| BG105270A (en) | Tetrahydropyridoethers | |
| TR200101126T2 (tr) | İkameli fenil türevleri, hazırlanma ve kullanımları | |
| EA200100411A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| CA2274464A1 (en) | Ketobenzamides as calpain inhibitors | |
| CY1107391T1 (el) | Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις | |
| HU9302335D0 (en) | 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines | |
| EA199800141A1 (ru) | Гетероциклические соединения | |
| CA2348735A1 (en) | Heterocyclic potassium channel inhibitors | |
| ZA979961B (en) | 5-HT1F agonists | |
| MX9605741A (es) | Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano. | |
| DE69912250D1 (de) | Phosphorylierte derivate des diaryl 1,3,4 oxadiazolon | |
| DE69716810D1 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
| WO2000021910A3 (en) | 1,2-disubstituted cyclopropanes | |
| BG104706A (en) | Derivatives of 1,3,4-oxadiazolone | |
| BG105731A (en) | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives | |
| MY138826A (en) | 2,7-substituted indoles | |
| TR200001010T2 (tr) | Ürokinaz önleyicileri olan izokinolinler. | |
| BG104983A (en) | Aryl fused azapolycyclic compounds | |
| ATE277017T1 (de) | 1,2-disubstituierte 1,4-dihydro-4-oxochinolin- verbindungen | |
| EP1034783A4 (de) | Amidederivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1056754 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |